Skip to main content

Table 4 Effect of OVX and OVXG on the lipidome of sheep in the long-term analysis

From: Effects of short- and long-term glucocorticoid-induced osteoporosis on plasma metabolome and lipidome of ovariectomized sheep

m/z

Lipid class

OVX vs Control

OVXG5 vs OVX

OVXG2 vs OVXG5

p

FC

FC

FC

FC

FC

FC

FC

FC

FC

FC

FC

FC

FC

FC

FC

   

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Trt

Time

Int

725.492

CL 72:6

1.20

0.91

1.16

0.98

1.05

0.89

0.96

0.99

1.06

0.90

1.06

1.05

0.91

0.90

1.04

0.018

0.082

0.023

752.511

CL 76:7

1.15

0.89

1.21

0.87

1.11

0.95

0.82

0.94

1.15

0.75

1.10

1.09

0.82

0.94

1.17

0.088

0.023

0.016

726.496

CL 72:5

1.19

0.91

1.19

0.95

1.02

0.88

0.98

0.87

1.06

0.88

1.19

1.05

1.01

0.97

1.05

0.03

0.026

0.018

751.518

CL 76:8

1.23

0.92

1.26

1.02

1.12

0.88

0.98

0.92

1.07

0.84

1.27

0.87

0.90

0.86

1.03

0.011

0.06

0.042

800.511

CL 84:15

1.15

0.85

1.16

0.97

1.07

0.92

0.93

0.87

0.99

0.88

1.03

1.26

1.10

0.93

1.04

0.027

0.06

0.005

686.546

CerP 39:1

1.21

0.91

1.21

1.02

1.09

0.97

0.93

0.99

1.08

0.80

1.08

1.22

0.86

0.83

1.13

0.042

0.071

0.014

660.543

CerP 37:0

1.17

0.93

1.16

0.99

1.10

0.94

0.91

0.88

1.04

0.92

1.04

1.13

0.91

0.99

1.00

0.019

0.029

0.045

785.429

PI 31:5

1.31

0.87

1.42

0.90

1.09

0.85

0.85

0.93

1.11

0.77

1.24

1.13

0.82

0.89

1.18

0.022

0.022

0.016

557.236

PI 14:0

1.43

0.73

1.52

0.81

1.14

0.89

0.76

1.02

1.20

0.80

1.20

1.30

0.69

0.83

1.03

0.12

0.153

0.019

543.316

PA 25:3

1.23

0.81

1.33

0.92

1.06

0.92

0.89

0.91

1.09

0.94

1.19

1.25

0.88

0.83

0.99

0.117

0.103

0.018

489.253

PA 21:2

1.40

0.79

1.31

0.94

0.93

0.86

0.94

0.90

1.24

0.90

1.13

1.13

0.86

0.79

1.04

0.099

0.046

0.024

464.323

lysoPE 18:0

1.44

0.83

1.41

0.93

1.19

0.77

0.88

0.82

1.04

0.92

1.33

1.16

0.95

0.90

0.93

0.014

0.004

0.043

558.243

PS 20:4

1.36

0.85

1.32

1.02

0.93

0.90

0.83

0.91

1.22

0.88

1.12

1.20

0.86

0.80

1.09

0.073

0.036

0.038

861.656

PG 42:0

1.39

0.84

1.22

1.00

0.89

0.89

0.93

0.90

1.26

0.98

1.03

1.16

0.92

0.80

0.99

0.138

0.185

0.026

  1. Relative intensities were measured in plasma samples of control group (n = 5), OVX group (n = 6), OVXG2 (n = 3) and OVXG5 (n = 3) using a linear mixed model. Results are fold changes (FC) of the lipid abundance between the OVXG5 and the OVX groups and between the OVXG2 and the OVXG5 groups from month one to month five, among identified compounds by LC-MS. FC with a value > 1 indicated a relatively higher intensity present in treated animals, whereas a value < 1 indicated a relatively lower intensity compared with their respective control animals
  2. All FC values, which are in bold, are significant at p < 0.05 calculated using post-hoc Fisher’s Least Significant Difference (LSD) test for pair-wise multiple comparison of the group means
  3. CL cardiolipin, CerP ceramide 1-phosphates, PI phosphatidylinositol, PA phosphatidic acid, lysoPE lysophosphatidylethanolamines, PS phosphatidylserines, PG phosphatidylglycerol